Pacer Advisors
RLAY icon

Pacer Advisors’s Relay Therapeutics RLAY Stock Holding History

Pacer Advisors’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55K Buy
+2,919
New +$42.4K ﹤0.01% 2014
2024
Q3 		– Sell
-1,103
Closed -$7.19K – 2673
2024
Q2 		$7.19K Sell
1,103
-1,054
-49% -$7.2K ﹤0.01% 3597
2024
Q1 		$17.9K Buy
+2,157
New +$21K ﹤0.01% 3464
2021
Q2 		– Sell
-1,981
Closed -$68K – 1535
2021
Q1 		$68K Buy
1,981
+432
+28% +$18.7K ﹤0.01% 1390
2020
Q4 		$64K Buy
+1,549
New +$70K ﹤0.01% 1399

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Pacer Advisors's RLAY Position: Q2 2026 in Review

Pacer Advisors opened a new position in Relay Therapeutics (RLAY) in Q2 2026: 2,919 shares worth $55K. The stake represents ﹤0.01% of the portfolio and ranks #2014 among its holdings. This is a return to the name: Pacer Advisors previously reported a position in RLAY as recently as Q2 2024.

Pacer Advisors first reported a position in RLAY in Q4 2020 and has held it in 5 quarters since. The position peaked at $68K in Q1 2021. 259 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Pacer Advisors held 2,919 shares of Relay Therapeutics worth $55K as of Q2 2026.
  • Relay Therapeutics was a new Pacer Advisors position in Q2 2026.
  • Relay Therapeutics made up ﹤0.01% of Pacer Advisors's portfolio in Q2 2026, its #2014 holding.
  • Pacer Advisors first reported a position in Relay Therapeutics in Q4 2020 and has held it in 5 quarters since.
  • Pacer Advisors's Relay Therapeutics position peaked at $68K in Q1 2021.
  • 259 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.